Las evidencias acumuladas en las ltimas dcadas respecto a la eficacia de los nuevos tratamientos farmacolgicos de la obesidad han convertido a la molcula del pptido anlogo al glucagn tipo1 (GLP-1) en un componente clave, ya sea en forma de monoagonistas, multiagonistas unimoleculares o combinaciones con efectos sobre diversos receptores1
The labs engage in Formulation Development, Analytical Method Development, API Process Development and Stability Studies
2003 Rats, full thickness wounds: Topical or intraperitoneal T4 increased re-epithelialization by 42% at 4 days and up to 61% at 7 days
In the absence of water, hydrolysis slows significantly and microbial activity is minimal
12-week assessment : Evaluate weight loss at 12 weeks on the 3.0 mg dose
Based on the known mechanisms of its components, clinical observers typically describe early texture changes within 24 weeks, improvements in fine lines and skin quality by 48 weeks, and structural remodelling and scar improvement by 812 weeks
